Transcriptional regulation of human survivin by early growth response (Egr)-1 transcription factor

被引:28
作者
Wagner, Mandy [1 ]
Schmelz, Karin [1 ]
Doerken, Bernd [1 ]
Tamm, Ingo [1 ]
机构
[1] Univ Med Berlin, Dept Hematol & Oncol, Charite, D-13353 Berlin, Germany
关键词
survivin; egr-1; transcription; apoptosis;
D O I
10.1002/ijc.23183
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Survivin, a member of the inhibitor of apoptosis protein family, is involved in both, inhibition of apoptosis and regulation of cell division. Because of the tumor-specific expression of survivin, the reduction of its expression is an important therapeutic option in the treatment of malignant diseases. Thus, we analyzed the transcriptional regulation of survivin in order to establish survivin as a target gene for new therapeutic approaches. Here, we describe a novel regulatory region within the survivin promoter. After treatment with phorbol 12-myristate-13-acetate, the early growth response (Egr)-1 transcription factor binds to the sequence 5' GAGGGGGCG 3' within the human survivin promoter in vitro and in entire cells. In reporter-gene assays and overexpression experiments, survivin is downregulated following exogenous expression of wildtype Egr-1. Using p53 wildtype and mutated cell lines, we show that Egr-1 negatively regulates survivin expression and sensitizes cell lines to TRAIL-induced apoptosis. (C) 2007 Wiley-Liss, Inc.
引用
收藏
页码:1278 / 1287
页数:10
相关论文
共 53 条
[1]   Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation [J].
Abdelrahim, Maen ;
Baker, Cheryl H. ;
Abbruzzese, James L. ;
Safe, Stephen .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (12) :855-868
[2]   FUNCTIONAL-SIGNIFICANCE OF AN OVERLAPPING CONSENSUS BINDING MOTIF FOR SP1 AND ZIF268 IN THE MURINE ADENOSINE-DEAMINASE GENE PROMOTER [J].
ACKERMAN, SL ;
MINDEN, AG ;
WILLIAMS, GT ;
BOBONIS, C ;
YEUNG, CY .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (17) :7523-7527
[3]   Egr1 transcription factor: Multiple roles in prostate tumor cell growth and survival [J].
Adamson, ED ;
Mercola, D .
TUMOR BIOLOGY, 2002, 23 (02) :93-102
[4]   Anti-apoptosis gene, survivin, and prognosis of neuroblastoma [J].
Adida, C ;
Berrebi, D ;
Peuchmaur, M ;
Reyes-Mugica, M ;
Altieri, DC .
LANCET, 1998, 351 (9106) :882-883
[5]   Validating survivin as a cancer therapeutic target [J].
Altieri, DC .
NATURE REVIEWS CANCER, 2003, 3 (01) :46-54
[6]   A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma [J].
Ambrosini, G ;
Adida, C ;
Altieri, DC .
NATURE MEDICINE, 1997, 3 (08) :917-921
[7]   Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis [J].
Chawla-Sarkar, M ;
Bae, SI ;
Reu, FJ ;
Jacobs, BS ;
Lindner, DJ ;
Borden, EC .
CELL DEATH AND DIFFERENTIATION, 2004, 11 (08) :915-923
[8]   Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors [J].
Chintharlapalli, Sudhakar ;
Papineni, Sabitha ;
Ramaiah, Shashi K. ;
Safe, Stephen .
CANCER RESEARCH, 2007, 67 (06) :2816-2823
[9]   DNA-BINDING SITE OF THE GROWTH FACTOR-INDUCIBLE PROTEIN ZIF268 [J].
CHRISTY, B ;
NATHANS, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) :8737-8741
[10]   REPRESSION OF THE INSULIN-LIKE GROWTH FACTOR-II GENE BY THE WILMS-TUMOR SUPPRESSOR WT1 [J].
DRUMMOND, IA ;
MADDEN, SL ;
ROHWERNUTTER, P ;
BELL, GI ;
SUKHATME, VP ;
RAUSCHER, FJ .
SCIENCE, 1992, 257 (5070) :674-678